These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31015097)

  • 21. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.
    Bevier M; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 Nov; 21(6):596-601. PubMed ID: 22387673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
    Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA
    Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer of unknown primary is associated with diabetes.
    Hemminki K; Försti A; Sundquist K; Li X
    Eur J Cancer Prev; 2016 May; 25(3):246-51. PubMed ID: 26011105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anthropometry, physical activity and cancer of unknown primary (CUP) risk: Results from the Netherlands cohort study.
    Hermans KEPE; van den Brandt PA; Loef C; Jansen RLH; Schouten LJ
    Cancer Epidemiol; 2020 Dec; 69():101836. PubMed ID: 33099214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Educational attainment and risk of HIV infection, response to antiretroviral treatment, and mortality in HIV-infected patients.
    Legarth R; Omland LH; Kronborg G; Larsen CS; Pedersen C; Gerstoft J; Obel N
    AIDS; 2014 Jan; 28(3):387-96. PubMed ID: 24670524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity.
    Dyrvig AK; Yderstræde KB; Gerke O; Jensen PB; Hess S; Høilund-Carlsen PF; Green A
    Medicine (Baltimore); 2017 Apr; 96(16):e6693. PubMed ID: 28422885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales.
    Tervonen HE; Walton R; You H; Baker D; Roder D; Currow D; Aranda S
    BMC Cancer; 2017 Jun; 17(1):398. PubMed ID: 28577351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden.
    Shu X; Sundquist K; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 May; 21(3):281-8. PubMed ID: 21968687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancers of Unknown Primary: A Descriptive Study in the U.S. Military Health System.
    Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
    Mil Med; 2023 Mar; 188(3-4):e516-e523. PubMed ID: 34296267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family history of cancer in first degree relatives and risk of cancer of unknown primary.
    Grewcock ALR; Hermans KEPE; Weijenberg MP; van den Brandt PA; Loef C; Jansen RLH; Schouten LJ
    Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13485. PubMed ID: 34224169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid reduction in the incidence of cancer of unknown primary. A population-based study.
    Brustugun OT; Helland Å
    Acta Oncol; 2014 Jan; 53(1):134-7. PubMed ID: 23550957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial Risk in Patients With Carcinoma of Unknown Primary.
    Samadder NJ; Smith KR; Hanson H; Pimentel R; Wong J; Boucher K; Akerley W; Gilcrease G; Ulrich CM; Burt RW; Curtin K
    JAMA Oncol; 2016 Mar; 2(3):340-6. PubMed ID: 26863281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of cancer of unknown primary after hospitalization for autoimmune diseases.
    Hemminki K; Sundquist K; Sundquist J; Ji J
    Int J Cancer; 2015 Dec; 137(12):2885-95. PubMed ID: 26103152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Location of metastases in cancer of unknown primary are not random and signal familial clustering.
    Hemminki K; Sundquist K; Sundquist J; Hemminki A; Ji J
    Sci Rep; 2016 Mar; 6():22891. PubMed ID: 26956545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient characteristics associated with definitive diagnosis of metastatic pancreatic cancer in those initially diagnosed with cancer of unknown primary.
    Lee White L; Smith-Gagen J; Elliott L; Lu M
    Mol Clin Oncol; 2023 Dec; 19(6):101. PubMed ID: 38022848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
    Randén M; Rutqvist LE; Johansson H
    Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer of Unknown Primary: a Cancer Registry Study of Factors Affecting Access to Diagnosis.
    Crawford SM; Skinner J; Coombes E; Jones AP
    Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):e39-e46. PubMed ID: 27720362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychiatric manifestations, personality traits and health-related quality of life in cancer of unknown primary site.
    Hyphantis T; Papadimitriou I; Petrakis D; Fountzilas G; Repana D; Assimakopoulos K; Carvalho AF; Pavlidis N
    Psychooncology; 2013 Sep; 22(9):2009-15. PubMed ID: 23359412
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.